Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $123.03 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $45.75 | 2 | $0 (2022) |
| AIMMUNE THERAPEUTICS, INC. | $23.20 | 1 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $15.75 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $14.80 | 1 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $12.22 | 1 | $0 (2018) |
| Allergan Inc. | $11.31 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.20 | 1 | AIMMUNE THERAPEUTICS, INC. ($23.20) |
| 2022 | $23.86 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($23.86) |
| 2021 | $36.69 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($21.89) |
| 2018 | $23.53 | 2 | Ferring Pharmaceuticals Inc. ($12.22) |
| 2017 | $15.75 | 1 | Valeant Pharmaceuticals North America LLC ($15.75) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Gastroenterology | ||||||
| 12/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Gastroenterology | ||||||
| 11/01/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Immunology | ||||||
| 06/28/2018 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR ORAL (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 520 | 546 | $219,220 | $51,272 |
| 2022 | 12 | 500 | 529 | $223,512 | $51,722 |
| 2021 | 12 | 561 | 609 | $222,972 | $58,290 |
| 2020 | 10 | 502 | 563 | $211,750 | $53,341 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 76 | 79 | $19,355 | $8,174 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $23,100 | $6,424 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $15,750 | $5,892 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 62 | $17,050 | $5,775 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 87 | $11,310 | $5,586 | 49.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $28,600 | $4,829 | 16.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $48,000 | $4,679 | 9.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 64 | $12,160 | $4,201 | 34.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $30,880 | $2,700 | 8.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $9,515 | $1,989 | 20.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 20 | $3,500 | $1,023 | 29.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 63 | 65 | $15,887 | $7,250 | 45.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 26 | 26 | $33,800 | $5,580 | 16.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $16,360 | $5,351 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 82 | $12,590 | $5,345 | 42.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 39 | 39 | $46,800 | $5,032 | 10.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $12,440 | $4,958 | 39.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 50 | $48,250 | $4,574 | 9.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 76 | $9,870 | $4,371 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 44 | $10,030 | $4,236 | 42.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $10,195 | $2,528 | 24.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 12 | 13 | $5,200 | $1,567 | 30.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 11 | $2,090 | $931.12 | 44.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 78 | 78 | $19,072 | $8,801 | 46.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 86 | 124 | $16,115 | $7,579 | 47.0% |
About Dr. Pradip Cherian, M.D
Dr. Pradip Cherian, M.D is a Gastroenterology healthcare provider based in Rydal, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508808478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pradip Cherian, M.D has received a total of $123.03 in payments from pharmaceutical and medical device companies, with $23.20 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($123.03).
As a Medicare-enrolled provider, Cherian has provided services to 2,083 Medicare beneficiaries, totaling 2,247 services with total Medicare billing of $214,625. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Rydal, PA
- Active Since 06/12/2006
- Last Updated 01/10/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1508808478
Products in Payments
- XIFAXAN (Drug) $45.75
- ZENPEP (Drug) $23.20
- RELISTOR ORAL (Drug) $15.75
- STELARA (Biological) $14.80
- CLENPIQ (Drug) $12.22
- LINZESS (Drug) $11.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rydal
Dr. Stuart Lubinski, M.d, M.D
Gastroenterology — Payments: $14,743
Dr. Cesar Delatorre, M.d, M.D
Gastroenterology — Payments: $2,877
Dr. Daniel Ringold, M.d, M.D
Gastroenterology — Payments: $2,130
Dr. Julia Binder, Md, MD
Gastroenterology — Payments: $1,099
Christina Brown, M.d, M.D
Gastroenterology — Payments: $1,072
Dr. Eric Goosenberg, M.d, M.D
Gastroenterology — Payments: $971.79